Evidence map›Paper›PMID 26412864›Full record

ArticleBiometrika2015

Efficient Estimation of Nonparametric Genetic Risk Function with Censored Data.

Yuanjia Wang, Baosheng Liang, Xingwei Tong, Karen Marder, Susan Bressman, Avi Orr-Urtreger, Nir Giladi, Donglin Zeng

Open access · greenAbstract read
In one paragraph

Article in Biometrika, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry.Movement disorders : official journal of the Movement Disorder Society · 2017
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Yuanjia WangDepartment of Biostatistics, Mailman School of Public Health, 722 W168th Street, New York 10032, U.S.A. yw2016@columbia.edu.
Baosheng LiangSchool of Mathematical Sciences, Beijing Normal University, Beijing 100875, China. liangbs@mail.bnu.edu.cn.
Xingwei TongSchool of Mathematical Sciences, Beijing Normal University, Beijing 100875, China. xweitong@bnu.edu.cn.
Karen MarderDepartment of Neurology and Psychiatry, College of Physicians and Surgeons, Columbia University, New York 10032, U.S.A. ksm1@columbia.edu.
Susan BressmanThe Alan and Barbara Mirken Department of Neurology, Beth Israel Medical Center, New York, 10003, U.S.A. sbressma@chpnet.org.
Avi Orr-UrtregerSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. aviorr@tasmc.health.gov.il.
Nir GiladiSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. nirg@tasmc.health.gov.il.
Donglin ZengDepartment of Biostatistics, CB # 7420, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7420, U.S.A. dzeng@bios.unc.edu.
Beijing Normal University · CNColumbia University · USTel Aviv University · ILMount Sinai Beth Israel · USUniversity of North Carolina at Chapel Hill · US

Funding

Statistical Methods for Cancer Clinical TrialsP01CA142538 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVIDIAN, MARIE, KOSOROK, MICHAEL R · 2010 to 2019
$21.3M
Statistical Methods for Integrating Mixed-type Biomarkers and Phenotypes in Neurodegenerative Disease ModelingR01NS073671 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, YUANJIA · 2011 to 2025
$3.9M
STATISTICAL METHODS IN CURRENT CANCER RESEARCHR01CA082659 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LIN, DANYU · 2000 to 2016
$3.7M
Semiparametric Regression Analysis of Censored DataR01GM047845 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LIN, DANYU · 1997 to 2018
$2.9M
Identifying Huntington's disease markers by modern statistical learning methods.U01NS082062 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, YUANJIA · 2014 to 2016
$1.1M
NCI NIH HHS P01 CA142538NCI NIH HHS R01 CA082659NIGMS NIH HHS R01 GM047845NINDS NIH HHS R01 NS073671NINDS NIH HHS U01 NS082062
6 · The paper itself

Abstract

With an increasing number of causal genes discovered for complex human disorders, it is crucial to assess the genetic risk of disease onset for individuals who are carriers of these causal mutations and compare the distribution of age-at-onset with that in non-carriers. In many genetic epidemiological studies aiming at estimating causal gene effect on disease, the age-at-onset of disease is subject to censoring. In addition, some individuals' mutation carrier or non-carrier status can be unknown due to the high cost of in-person ascertainment to collect DNA samples or death in older individuals. Instead, the probability of these individuals' mutation status can be obtained from various sources. When mutation status is missing, the available data take the form of censored mixture data. Recently, various methods have been proposed for risk estimation from such data, but none is efficient for estimating a nonparametric distribution. We propose a fully efficient sieve maximum likelihood estimation method, in which we estimate the logarithm of the hazard ratio between genetic mutation groups using B-splines, while applying nonparametric maximum likelihood estimation for the reference baseline hazard function. Our estimator can be calculated via an expectation-maximization algorithm which is much faster than existing methods. We show that our estimator is consistent and semiparametrically efficient and establish its asymptotic distribution. Simulation studies demonstrate superior performance of the proposed method, which is applied to the estimation of the distribution of the age-at-onset of Parkinson's disease for carriers of mutations in the leucine-rich repeat kinase 2 gene.

Indexed as

Empirical processMixture distributionParkinson's diseaseSemiparametric efficiencySieve maximum likelihood estimation

Identifiers

PMID26412864
PMCPMC4581539
OpenAlexW2105211429

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.